{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T12:24:08Z","timestamp":1789302248917,"version":"build-2803163510"},"reference-count":26,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We evaluated the impact of extended red blood cell (RBC) molecular matching on alloimmunization and transf usion-related outcomes in patients with sickle cell disease (SCD) and assessed the frequency and clinical significance of genotype\u2013 phenotype discrepancies. We conducted a retrospective analysis of 108 transfused patients with SCD who underwent phenotyping and molecular genotyping for clinically relevant RBC antigens. Patients were divided into two groups: those who received extended serologically matched RBC units (\n                    <jats:italic>n<\/jats:italic>\n                    = 55) and those who received extended molecularly matched RBC units (\n                    <jats:italic>n<\/jats:italic>\n                    = 53). Primary outcomes included the rate of alloimmunization, incidence of delayed hemolytic transfusion reactions (DHTRs), and the identification of antigen mismatches or discrepancies between genotype and phenotype. Molecular testing revealed clinically significant antigen mismatches in 42 percent of patients. Partial\n                    <jats:italic>RH<\/jats:italic>\n                    alleles were identified in 17 percent of patients. Discrepancies between genotype and phenotype were observed in 21.3 percent of patients. Alloimmunized patients were significantly more likely to have undetected mismatches. DHTRs after transfusion with RBC units that were serologically matched, but not molecularly compatible, were observed in two patients. In conclusion, extended RBC molecular matching improves the detection of clinically relevant antigen mismatches not identified by routine serologic methods and is associated with a lower risk of alloimmunization and transfusion-related complications.\n                  <\/jats:p>","DOI":"10.2478\/immunohematology-2025-017","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:26:49Z","timestamp":1767965209000},"page":"117-123","source":"Crossref","is-referenced-by-count":2,"title":["Improving transfusion outcomes in sickle cell disease through extended red blood cell molecular matching"],"prefix":"10.2478","volume":"41","author":[{"given":"Tamires D.","family":"Santos","sequence":"first","affiliation":[{"name":"Hemocentro Unicamp , Campinas, SP , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Castilho","sequence":"additional","affiliation":[{"name":"Hemocentro Unicamp , Campinas, SP , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"2026071214322109591_j_immunohematology-2025-017_ref_001","doi-asserted-by":"crossref","unstructured":"Smith-Whitley K, Thompson AA. Indications and complications of transfusions in sickle cell disease. Pediatr Blood Cancer 2012;59:358\u201364.","DOI":"10.1002\/pbc.24179"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_002","doi-asserted-by":"crossref","unstructured":"Chou ST, Liem RI, Thompson AA. Challenges of allo-immunization in patients with haemoglobinopathies. Br J Haematol 2012;159:394\u2013404.","DOI":"10.1111\/bjh.12061"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_003","doi-asserted-by":"crossref","unstructured":"Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322:1617\u201321.","DOI":"10.1056\/NEJM199006073222301"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_004","doi-asserted-by":"crossref","unstructured":"Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012;120: 528\u201337.","DOI":"10.1182\/blood-2011-11-327361"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_005","doi-asserted-by":"crossref","unstructured":"Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who receive transfusions. Transfusion 2002;42: 7\u201343.","DOI":"10.1046\/j.1537-2995.2002.00007.x"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_006","doi-asserted-by":"crossref","unstructured":"Khan J, Delaney M. Transfusion support of minority patients: extended antigen donor typing and recruitment of minority blood donors. Transfus Med Hemother 2018;45:271\u20136.","DOI":"10.1159\/000491883"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_007","doi-asserted-by":"crossref","unstructured":"Vichinsky EP. The prevention and management of allo-immunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. Immunohematology 2012;28:20\u20133.","DOI":"10.21307\/immunohematology-2019-144"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_008","doi-asserted-by":"crossref","unstructured":"Leal I, Santos TD, Gilli S, Castilho L. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with sickle cell disease (SCD). Transfus Apher Sci 2023;62:103813.","DOI":"10.1016\/j.transci.2023.103813"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_009","doi-asserted-by":"crossref","unstructured":"Osby M, Shulman IA. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005;129:190\u20133.","DOI":"10.5858\/2005-129-190-PMODRB"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_010","doi-asserted-by":"crossref","unstructured":"Chou ST, Alsawas M, Fasano RM, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020;4:327\u201355.","DOI":"10.1182\/bloodadvances.2019001143"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_011","doi-asserted-by":"crossref","unstructured":"Casas J, Friedman DF, Jackson T, Vege S, Westhoff CM, Chou ST. Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease. Transfusion 2015;55:1388\u201393.","DOI":"10.1111\/trf.12987"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_012","doi-asserted-by":"crossref","unstructured":"Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062\u201371.","DOI":"10.1182\/blood-2013-03-490623"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_013","unstructured":"Sippert E, Fujita CR, Machado D, et al. Variant RH alleles and Rh immunisation in patients with sickle cell disease. Blood Transfus 2015;13:72\u20137."},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_014","doi-asserted-by":"crossref","unstructured":"Castilho L . Molecular typing of blood group genes in diagnostics. Ann Blood 2021;30:1\u201310.","DOI":"10.21037\/aob-20-73"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_015","doi-asserted-by":"crossref","unstructured":"Wolf J, Blais-Normandin I, Bathla A, et al. Red cell specifications for blood group matching in patients with haemoglobinopathies: an updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines. Br J Haematol 2025; 206:94\u2013108.","DOI":"10.1111\/bjh.19837"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_016","doi-asserted-by":"crossref","unstructured":"Fichou Y, Audr\u00e9zet MP, Gu\u00e9guen P, Le Mar\u00e9chal C, F\u00e9rec C. Next-generation sequencing is a credible strategy for blood group genotyping. Br J Haematol 2014;167:554\u201362.","DOI":"10.1111\/bjh.13084"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_017","doi-asserted-by":"crossref","unstructured":"Fichou Y, Mariez M, Le Mar\u00e9chal C, F\u00e9rec C. The experience of extended blood group genotyping by next-generation sequencing (NGS): investigation of patients with sickle-cell disease. Vox Sang 2016;111:418\u201324.","DOI":"10.1111\/vox.12432"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_018","unstructured":"Noizat-Pirenne F, Lee K, Le Pennec PY, et al. Rare RHCE phenotypes in Black individuals of African origin: identification and implications for transfusion. Transfusion 2002;42:251\u20138."},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_019","doi-asserted-by":"crossref","unstructured":"Westhoff CM. The Rh blood group system in review: a new face for the next decade. Transfusion 2004;44:1663\u201373.","DOI":"10.1111\/j.0041-1132.2004.04237.x"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_020","doi-asserted-by":"crossref","unstructured":"Arnoni CP, Vendrame T, Muniz J, Cortez A, Latini F, Castilho L. RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors. Transfusion 2021;61:3473\u201382.","DOI":"10.1111\/trf.16689"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_021","doi-asserted-by":"crossref","unstructured":"Chou ST, Evans P, Vege S, et al. RH genotype matching for transfusion support in sickle cell disease. Blood 2012;120: 465\u201372.","DOI":"10.1182\/blood.V120.21.3239.3239"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_022","doi-asserted-by":"crossref","unstructured":"Castilho L, Rios M, Bianco C, et al. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Transfusion 2002;42:232\u20138.","DOI":"10.1046\/j.1537-2995.2002.00029.x"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_023","doi-asserted-by":"crossref","unstructured":"Menegati SFP, Santos TD, Macedo MD, Castilho L. Discrepancies between red cell phenotyping and genotyping in daily immunohematology laboratory practice. Transfus Apher Sci 2020;59:102585.","DOI":"10.1016\/j.transci.2019.06.020"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_024","doi-asserted-by":"crossref","unstructured":"Shih AW, Yan MTS, Elahie AL, et al. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk. Transfus Med 2020;30:263\u201374.","DOI":"10.1111\/tme.12685"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_025","doi-asserted-by":"crossref","unstructured":"da Costa DC, Pellegrino J Jr, Guelsin GA, Ribeiro KA, Gilli SC, Castilho L. Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients. Rev Bras Hematol Hemoter 2013;35:35\u20138.","DOI":"10.5581\/1516-8484.20130012"},{"key":"2026071214322109591_j_immunohematology-2025-017_ref_026","doi-asserted-by":"crossref","unstructured":"Westhoff CM, Floch A. Blood group genotype matching for transfusion. Br J Haematol 2025;206:18\u201332.","DOI":"10.1111\/bjh.19664"}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2025-017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:17:08Z","timestamp":1783901828000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2025-017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,31]]},"published-print":{"date-parts":[[2025,12,1]]}},"alternative-id":["10.2478\/immunohematology-2025-017"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2025-017","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}